• LAST PRICE
    3.2800
  • TODAY'S CHANGE (%)
    Trending Down-0.1100 (-3.2448%)
  • Bid / Lots
    3.2600/ 10
  • Ask / Lots
    3.4800/ 70
  • Open / Previous Close
    3.3800 / 3.3900
  • Day Range
    Low 3.2600
    High 3.3900
  • 52 Week Range
    Low 3.1400
    High 21.8800
  • Volume
    712,088
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 3.39
TimeVolumeMGNX
09:32 ET1031603.37
09:34 ET5003.35
09:38 ET6103.321
09:39 ET12903.3468
09:45 ET9003.365
09:50 ET1003.36
10:01 ET3003.36
10:03 ET1003.365
10:06 ET40913.3591
10:08 ET1003.365
10:10 ET4003.36
10:12 ET3003.35
10:14 ET11463.335
10:15 ET4003.335
10:17 ET7003.34
10:19 ET2003.345
10:21 ET13263.345
10:24 ET15623.3589
10:26 ET24793.355
10:28 ET3003.365
10:30 ET2263.365
10:32 ET4823.366
10:33 ET9263.36
10:35 ET1503.36
10:37 ET1003.36
10:39 ET1003.365
10:44 ET1003.36
10:51 ET12053.36
10:57 ET1003.36
11:04 ET198013.34
11:06 ET3073.335
11:08 ET30493.345
11:09 ET2003.34
11:11 ET8733.335
11:13 ET2053.335
11:18 ET57043.335
11:20 ET8183.335
11:22 ET1003.335
11:26 ET2283.33
11:27 ET3003.33
11:29 ET1523.33
11:31 ET4083.325
11:33 ET11083.315
11:36 ET5003.32
11:38 ET1113.325
11:40 ET7023.335
11:45 ET2623.34
11:49 ET9563.34
11:54 ET7003.33
11:56 ET2903.3288
12:00 ET79073.32
12:02 ET3503.32
12:03 ET1303.33
12:05 ET6503.3207
12:09 ET8163.325
12:14 ET5113.3186
12:16 ET19183.316
12:18 ET1203.3199
12:20 ET19703.305
12:23 ET37363.31
12:27 ET2113.31
12:30 ET1663.31
12:32 ET10203.305
12:36 ET3003.3099
12:38 ET17563.295
12:39 ET8943.3
12:41 ET1003.3
12:43 ET3003.3
12:45 ET3983.3002
12:48 ET10003.306882
12:50 ET6003.3
12:52 ET10263.305
12:54 ET2003.295
12:56 ET8123.295
12:57 ET1003.295
12:59 ET1003.295
01:01 ET39393.285
01:06 ET29123.28
01:08 ET5063.285
01:10 ET33003.29
01:12 ET12003.29
01:14 ET11503.28
01:15 ET3003.29
01:17 ET3003.28
01:19 ET3003.28
01:21 ET23103.29
01:24 ET4233.285
01:26 ET6073.2888
01:28 ET8303.275
01:30 ET35803.26
01:32 ET50613.27
01:33 ET63213.28
01:35 ET4003.285
01:37 ET5303.28
01:39 ET5353.28
01:42 ET5583.28
01:44 ET20523.295
01:46 ET32403.305
01:48 ET3003.3
01:50 ET8793.3
01:51 ET15053.3
01:53 ET13843.3
01:55 ET3093.29
01:57 ET2003.29
02:00 ET2003.29
02:02 ET5003.2988
02:04 ET5003.29
02:06 ET14563.29
02:08 ET21993.29
02:09 ET3503.29
02:11 ET8453.296
02:13 ET5003.29
02:15 ET4003.29
02:18 ET3003.29
02:20 ET4983.296
02:22 ET5663.29
02:24 ET6633.29
02:26 ET7503.285
02:27 ET3003.28
02:29 ET54063.285
02:31 ET18003.29
02:33 ET4003.29
02:36 ET4003.29
02:38 ET1943.29
02:40 ET13983.29
02:42 ET21003.3
02:44 ET5503.3
02:45 ET6903.31
02:47 ET2003.315
02:49 ET12003.325
02:51 ET28503.32
02:58 ET15003.32
03:00 ET5233.315
03:02 ET16503.31
03:03 ET10733.315
03:05 ET10143.315
03:07 ET15673.31
03:09 ET16383.3
03:12 ET21013.31
03:14 ET22053.31
03:16 ET19903.31
03:18 ET32213.3
03:20 ET4003.3
03:21 ET3003.305
03:23 ET38923.31
03:25 ET5003.305
03:27 ET12073.305
03:30 ET49733.305
03:32 ET34823.31
03:34 ET23433.31
03:36 ET3213.315
03:38 ET6573.315
03:39 ET15493.32
03:41 ET2773.32
03:43 ET5003.32
03:45 ET4003.32
03:48 ET24833.31
03:50 ET19503.3
03:52 ET95333.285
03:54 ET45833.295
03:56 ET102793.27
03:57 ET33993.275
03:59 ET2373903.28
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMGNX
MacroGenics Inc
212.6M
-1.5x
---
United StatesIPHA
Innate Pharma SA
185.3M
-4.8x
---
United StatesADAP
Adaptimmune Therapeutics PLC
258.3M
-2.9x
---
United StatesCDXS
Codexis Inc
227.7M
-2.8x
---
United StatesGNFT
Genfit SA
217.1M
-7.5x
---
United StatesRPTX
Repare Therapeutics Inc
148.6M
-2.2x
---
As of 2024-09-20

Company Information

MacroGenics, Inc. is a biopharmaceutical company focused on developing and commercializing monoclonal antibody-based therapeutics for the treatment of cancer. It generates its pipeline of product candidates primarily from its suite of antibody-based technology platforms, which have applicability across broad therapeutic domains. It is developing product candidates that target various tumor-associated antigens and immune checkpoint molecules. Its lead pipeline program is vobramitamab duocarmazine (vobra duo), an antibody-drug conjugate (ADC) that targets B7-H3, a molecule in the B7 family of immune regulator proteins that is expressed by several different tumor types. Its clinical pipeline includes two product candidates based on its, bispecific DART technology that co-engages both PD-1 and other checkpoint molecules. These candidates include lorigerlimab and tebotelimab. In addition, it is developing MGD024, a bispecific DART molecule. It is also developing various other programs.

Contact Information

Headquarters
9704 Medical Center DriveROCKVILLE, MD, United States 20850
Phone
301-251-5172
Fax
301-251-5321

Executives

Independent Chairman of the Board
William Heiden
President, Chief Executive Officer, Director
Scott Koenig
Chief Financial Officer, Senior Vice President, Corporate Secretary
James Karrels
Chief Operating Officer
Eric Risser
Senior Vice President - Research, Chief Scientific Officer
Ezio Bonvini

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$212.6M
Revenue (TTM)
$41.0M
Shares Outstanding
62.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.08
EPS
$-2.19
Book Value
$2.46
P/E Ratio
-1.5x
Price/Sales (TTM)
5.2
Price/Cash Flow (TTM)
---
Operating Margin
-357.86%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.